Skip to content

Clinical trials

Completed Thrombocythemia, Essential trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocythemia, Essential Status: Completed Country / region: Germany Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20053
20102
20132
20142
20181
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)2
Shire2
AOP Orphan Pharmaceuticals AG1
Constellation Pharmaceuticals1
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS1
Geron Corporation1
Italfarmaco1
Novartis Pharmaceuticals1
Sierra Oncology LLC - a GSK company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocythemia, Essential14
Primary Myelofibrosis9
Polycythemia Vera8
Myeloproliferative Disorders6
Leukemia, Myeloid, Acute4
Neoplasms4
Blast Crisis3
Breast Neoplasms3
Burkitt Lymphoma3
Hematologic Diseases3

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.